By Dow Jones Business News, January 29, 2014, 07:08:00 AM EDT By Ben Fox Rubin Biogen Idec Inc. ( BIIB ) on Wednesday said its fourth-quarter profit grew 57%, as sales of its multiple-sclerosis treatment Tecfidera continued to boost the biotechnology company's revenue. For the new year, the company projected adjusted earnings of $11.00 to $11.20 a share and revenue growth of 22% to 25% . Analysts polled by Thomson Reuters expected $11.63 a share in profit and revenue growth of 21%. Biogen recently launched Tecfidera, a pill for multiple sclerosis that analysts expect to steal significant market share from the injectable drugs that now dominate the market. The drug has had brisk early adoption from patients seeking easier-to-take drugs, despite having been approved after two rival oral drugs made by Biogen competitors. Biogen is aiming to become the dominant maker of MS treatments, a group of drugs that command high prices and that patients typically take for years. The company reported a profit of $457.3 million, or $1.92 a share, up from $292.1 million, or $1.23 a share, a year earlier. Excluding amortization and other items, per-share earnings grew to $2.34 from $1.40. Revenue jumped 39% to $1.97 billion. … Continue reading →

Denver, Colorado (PRWEB) January 28, 2014 Daily Gossip Magazine reveals in its Natural Multiple Sclerosis Treatment review that this program was actually created by Dr. Gary M Levin, an appreciated surgeon and health expert. To read more about Dr. Gary M. Levin's natural treatment for Multiple sclerosis visit the official website at: http://www.dailygossip.org/natural-multiple-sclerosis-treatment-review-7356 Levin says that even though multiple sclerosis can be a very discouraging condition, patients should know that a cure can be achieved for this disease. According to the author of Natural Multiple Sclerosis program, the reason why doctors cannot cure multiple sclerosis is actually linked to the fact that they dont understand the real cause of the disease. Dr. Gary claims that multiple sclerosis is in fact an autoimmune condition, caused by the overactive immune system. According to the Natural Multiple Sclerosis Treatment review, Gary Levin goes further to explain that the overactive immune system actually is the real problem that sufferers need to deal with in order to achieve a cure. Levins method to cure multiple sclerosis is detailed by the author in his guide, which naturally focuses on eliminating the cause of the disease. Levin says that strengthening the immune system will help sufferers improve … Continue reading →

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the 16th Annual BIO CEO & Investor Conference on Monday, February 10, 2014, at 11:30 a.m. EST in the Conrad Room. The conference will be held at the Waldorf=Astoria Hotel in New York, NY. A live webcast of the company presentation can be accessed here, or via the Investor Relations section of the Companys website at http://www.opexatherapeutics.com. An archive of the webcast will be available on the Company's website until May 11, 2014. About Opexa Opexas mission is to lead the field of Precision Immunotherapy by aligning the interests of patients, employees and shareholders. The Companys leading therapy candidate, Tcelna, is a personalized T-cell immunotherapy that is in a Phase IIb clinical development program (the Abili-T trial) for the treatment of SPMS. Tcelna is derived from T-cells isolated from a patients peripheral blood, expanded ex vivo, and reintroduced into the patient via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin. About Multiple Sclerosis (MS) … Continue reading →

Health JoNel Aleccia NBC News 18 hours ago CDC / CDC Toxins produced by Clostridium perfringens, a common cause of foodborne illness, could be a potential trigger for multiple sclerosis, scientists say. Add another clue to the mystery of multiple sclerosis: Scientists say a poison produced by common foodborne germs could be a trigger for the debilitating autoimmune disorder that affects 400,000 Americans. Researchers at Weill Cornell Medical College in New York have discovered that a toxin made by the bacterium Clostridium perfringens responsible for a million cases of food poisoning in the U.S. each year appears to attack the cells associated with MS. What weve shown is the toxins target the cells that are targeted in MS, said Jennifer Linden, a Weill Cornell researcher whos presenting findings Tuesday at a meeting of the American Society for Microbiology. Her research also showed that about 13 percent of a small sample of food products harbored C. perfringens bacteria, and nearly 3 percent were positive for the toxin linked to MS. Its too early to suggest that MS is caused by food poisoning, but it does raise the possibility that the C. perfringens bacteria could be involved in activating the disease, said … Continue reading →

The European Court of Human Rights has ruled in favour of Irish woman Louise OKeeffe in her landmark case against the Irish State, ruling that the Irish state failed to meet its obligation to protect Ms OKeeffe from the sexual abuse she suffered while a pupil in an Irish national school. Suzanne Lynch, Barry Roche Irish woman Louise OKeeffe, who today won a landmark case against the Irish State, said the ruling meant the Department of Education must protect children in schools. The European Court of Human Rights ruled this morning that the State had failed to meet its obligation to protect Ms OKeeffe from the sexual abuse she suffered while a pupil in an Irish national school. Ms O Keeffe had brought her case to the European Court after the Irish Supreme court ruled in 2009 that the State was not legally liable for the abuse suffered by Ms OKeeffe by her school principal while a nine-year old girl at Dunderrow National School. Speaking from Cork after the ruling Ms OKeeffe said: The message I have today for the Department of Education on foot of this ruling is that you must protect children in the schools, its a right … Continue reading →

The European Court of Human Rights has ruled in favour of Irish woman Louise OKeeffe in her landmark case against the Irish State, ruling that the Irish state failed to meet its obligation to protect Ms OKeeffe from the sexual abuse she suffered while a pupil in an Irish national school. Suzanne Lynch, Barry Roche Irish woman Louise OKeeffe, who today won a landmark case against the Irish State, said the ruling meant the Department of Education must protect children in schools. The European Court of Human Rights ruled this morning that the State had failed to meet its obligation to protect Ms OKeeffe from the sexual abuse she suffered while a pupil in an Irish national school. Ms O Keeffe had brought her case to the European Court after the Irish Supreme court ruled in 2009 that the State was not legally liable for the abuse suffered by Ms OKeeffe by her school principal while a nine-year old girl at Dunderrow National School. Speaking from Cork after the ruling Ms OKeeffe said: The message I have today for the Department of Education on foot of this ruling is that you must protect children in the schools, its a right … Continue reading →